“MEDEZE” Shares Insights on “Stem Cell Innovation” at Yuanta Seminar Transforming Healthcare into the Investment Frontier of the Future
Dr. Veerapol Khemarangsan, Chief Executive Officer of MEDEZE Group Public Company Limited (“MEDEZE”), participated as a guest speaker at the seminar “STEM CELL INNOVATION: Unlocking the Secrets of the Health Megatrend That Will Transform the Investment World.”
In his presentation, Dr. Veerapol shared in-depth knowledge and perspectives on stem cell innovation and regenerative medicine, highlighting it as one of the most promising medical technologies of the future driving global transformation in the healthcare industry. He also discussed pathways to translate medical innovation into investment opportunities within the emerging healthcare economy, under the theme “Healthcare Revolution: From Innovation to Investment – Transforming Healthcare into Investment Opportunities.”
Joining the discussion were Dr. Porntep Siriwanarangsan, Chairman of the Monitoring and Evaluation Committee for the Use of Advanced Therapy Medicinal Products (ATMPs) in Clinical Trials, and Mr. Thakol Banchongrak, Senior Director of Investment Research at Yuanta Securities (Thailand) Co., Ltd. The event was graced by Ms. Boonporn Boriboonsongsern, Chief Executive Officer, and Mr. Payuphat Mahaphon, Managing Director of Investment Banking, Yuanta Securities (Thailand) Co., Ltd., who warmly welcomed the speakers and participants.
The seminar took place at Gaysorn Urban Resort, 19th Floor, Bangkok, serving as an open forum for knowledge sharing and dialogue between experts in the medical and financial sectors—bridging the gap between innovative healthcare technologies and future investment potential.
IR Press Releases